| Product Code: ETC7657630 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Oncology-Cancer Drugs Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Oncology-Cancer Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Oncology-Cancer Drugs Market - Industry Life Cycle |
3.4 Israel Oncology-Cancer Drugs Market - Porter's Five Forces |
3.5 Israel Oncology-Cancer Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Israel Oncology-Cancer Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Israel Oncology-Cancer Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Israel |
4.2.2 Technological advancements in oncology-cancer drug research and development |
4.2.3 Growing investments in healthcare infrastructure and facilities |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approvals in Israel |
4.3.2 High cost associated with oncology-cancer drug development and treatment |
5 Israel Oncology-Cancer Drugs Market Trends |
6 Israel Oncology-Cancer Drugs Market, By Types |
6.1 Israel Oncology-Cancer Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Israel Oncology-Cancer Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Israel Oncology-Cancer Drugs Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.1.4 Israel Oncology-Cancer Drugs Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.1.5 Israel Oncology-Cancer Drugs Market Revenues & Volume, By Immunotherapy (Biologic Therapy), 2021- 2031F |
6.1.6 Israel Oncology-Cancer Drugs Market Revenues & Volume, By Hormonal Therapy, 2021- 2031F |
6.2 Israel Oncology-Cancer Drugs Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Israel Oncology-Cancer Drugs Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.3 Israel Oncology-Cancer Drugs Market Revenues & Volume, By Stomach Cancer, 2021- 2031F |
6.2.4 Israel Oncology-Cancer Drugs Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.5 Israel Oncology-Cancer Drugs Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.6 Israel Oncology-Cancer Drugs Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.7 Israel Oncology-Cancer Drugs Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.2.8 Israel Oncology-Cancer Drugs Market Revenues & Volume, By Other Cancers, 2021- 2031F |
6.2.9 Israel Oncology-Cancer Drugs Market Revenues & Volume, By Other Cancers, 2021- 2031F |
7 Israel Oncology-Cancer Drugs Market Import-Export Trade Statistics |
7.1 Israel Oncology-Cancer Drugs Market Export to Major Countries |
7.2 Israel Oncology-Cancer Drugs Market Imports from Major Countries |
8 Israel Oncology-Cancer Drugs Market Key Performance Indicators |
8.1 Average patient survival rates for specific types of cancer |
8.2 Adoption rate of innovative oncology-cancer drugs in clinical practice |
8.3 Number of clinical trials conducted for oncology-cancer drugs in Israel |
8.4 Rate of successful outcomes in cancer treatment using new therapies |
8.5 Patient satisfaction scores with oncology-cancer treatment facilities and services |
9 Israel Oncology-Cancer Drugs Market - Opportunity Assessment |
9.1 Israel Oncology-Cancer Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Israel Oncology-Cancer Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Israel Oncology-Cancer Drugs Market - Competitive Landscape |
10.1 Israel Oncology-Cancer Drugs Market Revenue Share, By Companies, 2024 |
10.2 Israel Oncology-Cancer Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here